Optimizing Dosing and Fixed-Dose Combinations of Rifampicin, Isoniazid, and Pyrazinamide in Pediatric Patients With Tuberculosis: A Prospective Population Pharmacokinetic Study is a research paper published in Clinical Infectious Diseases (2021). On theSindex it has a DataRank of 0.533. It has been cited 34 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.533
From this paper's citation signal
Citation Network Contribution
0
Citation network not refreshed for this result
This paper's DataRank is currently driven only by its base citation score. Citation network data was not refreshed for this result.
Learn more about DataRank methodology →Eunice Kennedy Shriver National Institute of Child Health and Human Development
Grant: R01HD069175
Wellcome Trust
Grant: 206379/Z/17/Z
European Union
Grant: TRIA2015-1102
National Institutes of Health
Grant: UM1 AI068634
National Institutes of Health
Grant: UM1 AI068636,
National Institutes of Health
Grant: UM1 AI106701
NIAID NIH HHS
Grant: UM1 AI068636
European & Developing Countries Clinical Trials Partnership (EDCTP)
SA-MRC
PanACEA
National Institute of Allergy and Infectious Diseases
FWCI
1.24
Citation Percentile
0.8%
Influential Citations
2
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals